NIH Reporter #1R21NS138711-01A1

NIH Grant for Research on Post-Ischemic White Matter Protection Using CK2 Inhibitor

This opportunity is a research grant from the National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, focused on therapies for protecting white matter after ischemic stroke. - Government Buyer: - National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) - Products/Services Requested: - Research project on post-ischemic white matter protection - Utilization of an FDA-approved CK2 inhibitor - Longitudinal MRI studies, behavioral assessments, and molecular analyses in rodent models - Emphasis on sex and age differences in research subjects - OEMs and Vendors: - No specific OEMs or commercial vendors are named, as this is a scientific research grant - Unique/Notable Requirements: - Use of an FDA-approved CK2 inhibitor - Focus on both sex and age differences in experimental design - Research to be conducted at Oregon Health & Science University, Portland, OR - Estimated grant value: $429,000

Description

This is a research grant opportunity focused on developing therapies to protect white matter after ischemic stroke, utilizing an FDA-approved CK2 inhibitor. The project involves longitudinal MRI studies, behavioral assessments, and molecular analyses in rodent models, with a focus on sex and age differences. The research aims to advance understanding and treatment of post-ischemic white matter damage.

View original listing